The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

被引：1
|
作者：
Kim, Young-Hoon [1 ]
Shim, Jaemin [1 ]
Tsai, Chia-Ti [2 ]
Wang, Chun-Chieh [3 ]
Vilela, Gilbert [4 ]
Muengtaweepongsa, Sombat [5 ]
Kurniawan, Mohammad [6 ]
Maskon, Oteh [7 ]
Hsu, Li Fern [8 ]
Thang Huy Nguyen [9 ]
Sim, Kenneth [10 ]
Camm, A. John [11 ,12 ]
机构：
[1] Korea Univ, Med Ctr, Seoul, South Korea
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Chang Gung Univ, Chang Gung Mem Hosp, Taoyuan, Taiwan
[4] Philippine Heart Ctr, Quezon City, Philippines
[5] Thammasat Univ, Stroke Excellence Ctr, Fac Med, Pathum Thani, Thailand
[6] Univ Indonesia, Dept Neurol, Cipto Mangunkusumo Natl Hosp, Fac Med, Jakarta, Indonesia
[7] Natl Univ Malaysia, Dept Med, Med Ctr, Kuala Lumpur, Malaysia
[8] Mt Elizabeth Novena Specialist Ctr, Novena Heart Ctr, Singapore, Singapore
[9] Pham Ngoc Thach Med Univ, Dept Neurol, Ho Chi Minh City, Vietnam
[10] Bayer South East Asia Pte Ltd, Singapore, Singapore
[11] Univ London, Cardiol Clin Acad Grp St Georges, London, England
[12] Imperial Coll, London, England
来源：
CHEST | 2019年 / 155卷 / 06期
关键词：
ANTAGONIST ORAL ANTICOAGULANTS; STROKE PREVENTION; WARFARIN; DABIGATRAN; ASIANS;
D O I：
10.1016/j.chest.2019.03.036
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1309 / 1311
页数：4
相关论文
共 50 条
  • [1] The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban Response
    Lip, Gregory Y. H.
    Ruff, Christian T.
    Moores, Lisa
    CHEST, 2019, 155 (06) : 1311 - 1312
  • [2] Antithrombotic therapy in atrial fibrillation: new data and new horizons
    Gilyarov, M. Yu.
    Sulimov, V. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (01) : 75 - 81
  • [3] The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report
    Moore, Kenneth T.
    CHEST, 2019, 155 (06) : 1306 - 1307
  • [4] Recent Progress in Antithrombotic Therapy for Atrial Fibrillation
    Velu, Selvakumar
    Lip, Gregory Y. H.
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (04) : 257 - 273
  • [5] Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician
    Lopes, Renato D.
    Piccini, Jonathan P.
    Hylek, Elaine M.
    Granger, Christopher B.
    Alexander, John H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 26 (03) : 167 - 174
  • [6] Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician
    Renato D. Lopes
    Jonathan P. Piccini
    Elaine M. Hylek
    Christopher B. Granger
    John H. Alexander
    Journal of Thrombosis and Thrombolysis, 2008, 26 : 167 - 174
  • [7] The Use of Rivaroxaban in Patients With Atrial Fibrillation Receiving Hemodialysis-Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report Response
    Lip, Gregory Y. H.
    Ruff, Christian T.
    Moores, Lisa
    CHEST, 2019, 155 (06) : 1307 - 1307
  • [8] Antithrombotic therapy in atrial fibrillation: an assessment of compliance with guidelines
    Nair, Anil
    Hazell, Wayne
    Sutton, Timothy
    Pillai, Sandhya
    NEW ZEALAND MEDICAL JOURNAL, 2005, 118 (1208)
  • [9] Antithrombotic Therapy in Patients with Recent Stroke and Atrial Fibrillation
    Saberwal, Bunny
    Ioannou, Adam
    Lim, Wei Y.
    Beirne, Anne-Marie
    Chow, Anthony W.
    Tousoulis, Dimitris
    Ahsan, Syed
    Papageorgiou, Nikolaos
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (23) : 2715 - 2724
  • [10] Predictors of adherence to antithrombotic therapy guidelines for stroke prevention in atrial fibrillation: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING)
    Farmakis, D. T.
    Pipilis, A.
    Antoniou, A.
    Kaliambakos, S.
    Goudevenos, J.
    Lekakis, J.
    EUROPEAN HEART JOURNAL, 2013, 34 : 189 - 189
12345